Ethambutol-induced optic neuropathy.

IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Biomedical Papers-Olomouc Pub Date : 2023-09-01 Epub Date: 2022-05-16 DOI:10.5507/bp.2022.022
Martin Kyncl, Martin Fus, Jan Lestak
{"title":"Ethambutol-induced optic neuropathy.","authors":"Martin Kyncl,&nbsp;Martin Fus,&nbsp;Jan Lestak","doi":"10.5507/bp.2022.022","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>A case report of a 40-year-old patient with tuberculosis treated with ethambutol is described. Within six months of starting treatment, there was a painless sudden decline in visual function. Despite the known complications of ethambutol treatment, it was discontinued after another three months.</p><p><strong>Methods: </strong>In the case report, we highlight the damage to the dominantly peripheral visual pathways. Using electrophysiological examinations, we showed a significant alteration in the optic nerves. Optical Coherence Tomography (OCT) showed progressive loss of vessel density and nerve fibre layer of retinal ganglion cells. Perimetric examination showed both a central decrease in sensitivity and mainly scotomas in the temporal parts of the visual fields. Although there was improvement in visual fields over time, OCT findings indicated progression of ethambutol-induced optic neuropathy (EON). Magnetic Resonance Imaging confirmed the alteration in the peripheral part of the visual pathway (intraorbital, intracranial parts of optic nerves, chiasma, and optic tracts).</p><p><strong>Conclusion: </strong>Even though EON is not an unknown complication, new cases still occur and, unfortunately, with an irreversible course. Therefore, it is important to draw attention constantly to this complication and to consider it not only in ophthalmologists' surgeries.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":"167 3","pages":"288-293"},"PeriodicalIF":0.7000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Papers-Olomouc","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5507/bp.2022.022","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/16 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: A case report of a 40-year-old patient with tuberculosis treated with ethambutol is described. Within six months of starting treatment, there was a painless sudden decline in visual function. Despite the known complications of ethambutol treatment, it was discontinued after another three months.

Methods: In the case report, we highlight the damage to the dominantly peripheral visual pathways. Using electrophysiological examinations, we showed a significant alteration in the optic nerves. Optical Coherence Tomography (OCT) showed progressive loss of vessel density and nerve fibre layer of retinal ganglion cells. Perimetric examination showed both a central decrease in sensitivity and mainly scotomas in the temporal parts of the visual fields. Although there was improvement in visual fields over time, OCT findings indicated progression of ethambutol-induced optic neuropathy (EON). Magnetic Resonance Imaging confirmed the alteration in the peripheral part of the visual pathway (intraorbital, intracranial parts of optic nerves, chiasma, and optic tracts).

Conclusion: Even though EON is not an unknown complication, new cases still occur and, unfortunately, with an irreversible course. Therefore, it is important to draw attention constantly to this complication and to consider it not only in ophthalmologists' surgeries.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乙胺丁醇引起的视神经病变。
目的:报告一例40岁肺结核患者用乙胺丁醇治疗的病例。在开始治疗的六个月内,视觉功能出现无痛性突然下降。尽管已知乙胺丁醇治疗有并发症,但在三个月后停止使用。方法:在病例报告中,我们强调了主要周围视觉通路的损伤。通过电生理检查,我们发现视神经发生了显著变化。光学相干断层扫描(OCT)显示视网膜神经节细胞的血管密度和神经纤维层逐渐丧失。周边检查显示敏感度中心下降,主要是视野颞部的暗点。尽管随着时间的推移,视野有所改善,但OCT结果表明乙胺丁醇诱导的视神经病变(EON)进展。磁共振成像证实了视觉通路外围部分(眶内、视神经颅内部分、交叉和视束)的改变。结论:尽管EON不是一种未知的并发症,但仍会出现新病例,不幸的是,其病程不可逆转。因此,重要的是要不断引起人们对这种并发症的关注,并不仅仅在眼科医生的手术中考虑它。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Biomedical Papers-Olomouc
Biomedical Papers-Olomouc MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.30
自引率
0.00%
发文量
74
审稿时长
6-12 weeks
期刊介绍: Biomedical Papers is a journal of Palacký University Olomouc, Faculty of Medicine and Dentistry, Olomouc, Czech Republic. It includes reviews and original articles reporting on basic and clinical research in medicine. Biomedical Papers is published as one volume per year in four issues.
期刊最新文献
Contemporary review of prognostic markers of prostate cancer from a pathologist perspective. Awareness and knowledge of diabetic retinopathy in diabetics and non-diabetics: A descriptive cross-sectional study. Two de novo UBR1 variants in trans as a cause of Johanson-Blizzard syndrome. The burden of multimorbidity in patients with systemic lupus erythematosus - single-centre analysis. FOXP3, IL-35, and PD-L1 in intra- and peritumoral lymphocytic infiltrate of cutaneous melanomas as an important part of antitumor immunity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1